| Kristen Nicole Smith, | |
|
1800 N Missouri St Ste 2, West Memphis, AR 72301-1750 | |
| (870) 735-8987 | |
| Not Available |
| Full Name | Kristen Nicole Smith |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1800 N Missouri St Ste 2, West Memphis, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437873403 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD16270 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Nicole Smith, 1800 N Missouri St Ste 2, West Memphis, AR 72301-1750 Ph: () - | Kristen Nicole Smith, 1800 N Missouri St Ste 2, West Memphis, AR 72301-1750 Ph: (870) 735-8987 |
News Archive
Like weeds sprouting from cracks in the pavement, cancer often forms in sites of tissue damage. That damage could be an infection, a physical wound, or some type of inflammation.
Lymphoma Foundation Canada (LFC) applauds Ontario's recent decision to publicly fund Rituxan (rituximab) in combination with Fludarabine-based chemotherapy for patients with previously untreated chronic lymphocytic leukemia (CLL).
CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners and Pappas Ventures all participated in the financing. CeNeRx plans to use the proceeds to conduct a Phase II trial of its improved formulation of its novel antidepressant TriRima™.
Researchers utilizing an advanced magnetic resonance imaging (MRI) technology to characterize and chart the evolution of MS lesions found that relapsing-remitting multiple sclerosis (RRMS) patients treated with COPAXONE (glatiramer acetate injection) experienced significantly increased magnetization transfer ratio.
GE Healthcare, a unit of GE, and Dyax Corp. today announced a licensing agreement for the development and commercialization of peptides binding to c-Met, which provides upfront, milestone, and royalty payments to Dyax.
› Verified 6 days ago
Vlad Gamalie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 N Missouri St, West Memphis, AR 72301 Phone: 870-735-8987 | |
Dr. John R Spotts, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 N Missouri St, Suite 2, West Memphis, AR 72301 Phone: 870-702-6515 Fax: 870-733-0594 | |
Dr. Mary Williams, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 I-40 Service Road, West Memphis, AR 72301 Phone: 870-732-0283 | |
Dr. Nita Kay Allison, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 798 W Service Rd, West Memphis, AR 72301 Phone: 870-735-2324 Fax: 870-732-2926 | |
Dr. Jason C Mckewen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Tyler Ave, West Memphis, AR 72301 Phone: 870-732-7701 | |
Shannon Mcelroy, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 I-40 Service Rd, West Memphis, AR 72301 Phone: 870-732-0283 | |
Dr. Tiffany J Martin, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 346 W Broadway St, West Memphis, AR 72301 Phone: 870-733-0138 Fax: 870-733-0237 |